Mel Krajden mainly investigates Immunology, Virology, Internal medicine, Hepatitis C and Hepatitis C virus. His Immunology research is multidisciplinary, incorporating elements of Incidence and Intensive care medicine. Virology and Interim are commonly linked in his work.
His research integrates issues of Ribavirin, Gynecology and Gastroenterology in his study of Internal medicine. His biological study spans a wide range of topics, including Pharmacotherapy, Quality of life, Antiviral therapy and Treatment failure. The study incorporates disciplines such as Cirrhosis, Disease burden and Cohort in addition to Hepatitis C virus.
His primary scientific interests are in Internal medicine, Virology, Hepatitis C, Hepatitis C virus and Immunology. His research in Internal medicine intersects with topics in Gastroenterology, Ribavirin and Oncology. Mel Krajden frequently studies issues relating to Genotype and Virology.
His studies in Hepatitis C integrate themes in fields like Hepatitis B, Epidemiology, Cohort study, Public health and Cohort. His study in Hepatitis C virus is interdisciplinary in nature, drawing from both Liver disease, Hepatocellular carcinoma and Disease burden. His Immunology research incorporates themes from Odds ratio and Hazard ratio.
The scientist’s investigation covers issues in Internal medicine, Cohort, Hepatitis C virus, Hepatitis C and Hepatitis. His work deals with themes such as Hcv treatment, Cytology and Oncology, which intersect with Internal medicine. His Cohort study incorporates themes from Men who have sex with men, Incidence, Retrospective cohort study, Public health and Direct acting.
His Hepatitis C virus research incorporates elements of Epidemiology and Transplantation. His Hepatitis C study also includes
Mel Krajden mainly focuses on Internal medicine, Virology, Hepatitis C, Cohort and Hepatitis C virus. His Internal medicine research includes elements of Cytology and Oncology. His Virology study integrates concerns from other disciplines, such as Pandemic, Coronavirus disease 2019, Coronavirus and Severe acute respiratory syndrome coronavirus 2.
He interconnects Hepatitis B, Chronic hepatitis, Cohort study and Hepatocellular carcinoma in the investigation of issues within Hepatitis C. His Hepatitis B research is multidisciplinary, relying on both Disease burden and Hepatitis B virus. His Cohort study combines topics from a wide range of disciplines, such as Medical prescription, Prescription drug and Hepatitis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Genome Sequence of the SARS-associated Coronavirus
Marco A. Marra;Steven J. M. Jones;Caroline R. Astell;Robert A. Holt.
Identification of Severe Acute Respiratory Syndrome in Canada
Susan M. Poutanen;Susan M. Poutanen;Donald E. Low;Bonnie Henry;Sandy Finkelstein.
The New England Journal of Medicine (2003)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif.
The Lancet Gastroenterology & Hepatology (2017)
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen.
The Lancet Gastroenterology & Hepatology (2018)
Human illness from avian influenza H7N3, British Columbia.
S. Aleina Tweed;Danuta M. Skowronski;Samara T. David;Andrew Larder.
Emerging Infectious Diseases (2004)
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.
Simon R. M. Dobson;Shelly McNeil;Marc Dionne;Meena Dawar.
Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
Danuta M. Skowronski;Naveed Z. Janjua;Gaston De Serres;Suzana Sabaiduc.
PLOS ONE (2014)
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P. Bruggmann;T. Berg;A. L. H. Øvrehus;C. Moreno.
Journal of Viral Hepatitis (2014)
Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting
Julio S.G. Montaner;Viviane D. Lima;P. Richard Harrigan;Lillian Lourenço.
PLOS ONE (2014)
Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients.
Atul Humar;Daniel Gregson;Angela M. Caliendo;Allison McGeer.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: